Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03944772 |
|---|---|
| Brief Title: | Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) (ORCHARD) |
| First Submitted : | April 29, 2019 |
| First Submitted that Met QC Criteria : | May 8, 2019 |
| First Posted : | May 10, 2019 |
| Last Update Submitted that Met QC Criteria : | May 10, 2024 |
| Last Update Posted : | May 13, 2024 |